Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceuticals worldwide. The company offers medications for diabetes, obesity, cancer, and more.
Explore more US and African stocks, read the latest market news, or compare African stock exchanges on Wallflake.
Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceuticals worldwide. The company offers medications for diabetes, obesity, cancer, and more. Eli Lilly and Company operates in the Healthcare sector and trades on the New York Stock Exchange under the ticker LLY.
Eli Lilly and Company is listed on the New York Stock Exchange, where it trades under the ticker symbol LLY. It is classified in the Healthcare sector.
LLY last traded at USD 1,139.48 on 4 September 2026, down 1.74% on the session. Live prices for Eli Lilly and Company update through the trading day on Wallflake.
Eli Lilly and Company has a market capitalisation of approximately USD 1.02T, based on its closing price on 4 September 2026.
Over the past 52 weeks LLY has traded between a low of USD 712.05 and a high of USD 1,292.65.
Yes. Eli Lilly and Company pays a dividend, with a trailing yield of 0.60%. Its payout ratio is approximately 21.69%.
LLY has a price-to-earnings (P/E) ratio of 49.82 and earnings per share (EPS) of USD 22.95. These figures are reported metrics, not a valuation opinion — Wallflake does not issue buy, sell or hold recommendations.
LLY shares are bought and sold through a broker licensed to trade on the New York Stock Exchange. You open an account with a licensed broker, fund it, and place an order quoting the ticker LLY. Wallflake is a market-data and research platform, not a broker, and does not execute trades or give investment advice. See our New York Stock Exchange guide for how the market works. Read the guide
Figures are drawn from Wallflake's market data and are provided for information only. Nothing here is investment advice or a recommendation to buy or sell any security.